Low-dose diclofenac potassium in U.K.
This article was originally published in The Tan Sheet
The Medicines and Healthcare Products Regulatory Agency moves a low dosage of diclofenac potassium, a non-steroidal anti-inflammatory drug, from prescription-only status to pharmacy class. Diclofenac potassium 12.5 mg tablets may be supplied without a prescription - similar to what is called "behind the counter" in the U.S. - to adults and children ages 14 and up to provide short-term relief from headaches, symptoms associated with flu or cold and mild to moderate pain relief, according to a July 8 update by MHRA. Diclofenac potassium is available in the U.S. only in 50 mg prescription products, according to FDA records...
You may also be interested in...
Business development leaders and venture capital investors spoke at Biocom’s annual partnering conference about what they are seeking in relationships with entrepreneurs and start-ups.
Mylan’s full year 2019 earnings report was its last as an independent company, so the focus was on the coming merger with Pfizer’s Upjohn and growth prospects for the new company, Viatris.
Colgate Zero toothpastes and mouthwashes promote what’s missing; Tom’s of Maine natural personal care expands with prebiotic toothpaste, deodorant and hand soap; Gaia adds hemp to its herbs; and Church & Dwight goes environmentally friendly with VitaFusion Goodness supplements, adds CBD versions to line, too.